Investigation of Radiation Retinopathy (RadiRet Study)Subtitle: Influence of Lucentis® on radiation retinopathy after irradiation of choroidal melanoma - RadiRet Study

Charité – University Medicine Berlin0 个研究点目标入组 60 人开始时间: 2012年8月3日最近更新: 2021年9月13日

适应症

试验速览

暂无简介。

•Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)
•Visual impairment due to focal or diffuse radiation induced ME in the irradiated eye that is eligible for laser treatment
•Age =18 years
•BCVA less than 20/32
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 30
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 30

•Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula
•Endoresection and / or previous vitrectomy
•Patients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome
•Treatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation
•Prior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry

发起方